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license (http://creativeto-moderate dementia of Alzheimer’s type when compared with healthy individuals. Mild cognitive
impairment (MCI) is the predementia stage of the disease. The main purpose was to investigate if
these changes are seen in MCI.
Methods: Retinal vessel oxygen saturation was measured in 42 patients with MCI and 42 healthy
individuals with a noninvasive retinal oximeter, Oxymap T1. The groups were paired according to
age.
Results: Arteriolar and venular oxygen saturation was increased in MCI patients compared to
healthy individuals (arterioles: 93.1 6 3.7% vs. 91.1 6 3.4%, P 5 .01; venules: 59.6 6 6.1% vs.
54.9 6 6.4%, P 5 .001). Arteriovenous difference was decreased in MCI compared to healthy indi-
viduals (33.5 6 4.5% vs. 36.2 6 5.2%, P 5 .01).
Discussion: Increased retinal vessel oxygen saturation and decreased arteriovenous difference in
MCI could reflect less oxygen extraction by retinal tissue. This indicates that retinal oxygen meta-
bolism may be affected in patients with MCI.
 2018 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Keywords: Mild cognitive impairment; Alzheimer’s disease; Oximetry; Retina; Retinal vessels; Oxygen saturation; Spectro-photometry1. Background
Mild cognitive impairment (MCI) is a broad term that can
be defined as an early stage of Alzheimer’s disease (AD) as
well as of other types of dementias [1]. Some individuals
withMCI are however stable and can even recover [2]. Com-
plaints about visual impairment are common in AD patients
[3], and retinal vascular abnormalities have been found in
patients with AD [4]. There is some evidence of thinning
of the retinal nerve fiber layer (RNFL) in MCI [5,6] andthor. Tel.: 1354 864 0478; Fax: 1354 543 9918.
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he Authors. Published by Elsevier Inc. on behalf of the Alzhe
commons.org/licenses/by-nc-nd/4.0/).AD [7–12] as well as with progression from MCI to severe
AD [6]. It has been suggested that this may help in diagnosis
and also to evaluate progression [13].
Einarsdottir et al. measured difference in retinal oxygen
metabolism in mild-to-moderate Alzheimer’s dementia and
found increased vessel oxygen saturation compared to
healthy individuals [14]. In other retinal oximetry studies
in retinal atrophic diseases such as in glaucoma, increased
venular oxygen saturation and decreased arteriovenous dif-
ference (oxygen uptake) were correlated with worse glau-
comatous visual fields [15,16] and thinner RNFLs [17].
Biomarkers for AD have gained increased recognition
and include cerebrospinal fluid protein biomarkers (total
tau, phospho-tau, and b amyloid-42), amyloid imagingimer’s Association. This is an open access article under the CC BY-NC-ND
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aging for evaluation of medial temporal lobe atrophy
(MTA). These methods are however invasive and/or expen-
sive, and there is still a need for simpler and reliable bio-
markers of the disease. The purpose of the study was to
test whether retinal oxygen metabolism is abnormal in AD
in the stage of MCI when compared with healthy individuals
and to examine whether retinal oximetry can serve as a
noninvasive biomarker for early AD.2. Methods
2.1. Study population
This study is a part of a larger study on progression of
cognitive impairment in MCI. All participants signed an
informed consent which followed the Tenets of the Declara-
tion of Helsinki (www.wma.net/policy). The study is a case-
control study.
Patients were diagnosed at the Memory Clinic of the
Geriatric Department, Landspitali University Hospital, Rey-
kjavik, Iceland. The diagnosis of MCI for inclusion in the
study was made according to the Petersen criteria [18,19]
based on information on cognitive impairment compared
to earlier abilities from the patients and their relatives but
without any change in abilities of daily life. The Informant
Questionnaire on Cognitive Decline in the Elderly [20]
was used in evaluating the changes seen by the relatives dur-
ing the preceding years. An Mini Mental State Examination
score [21] of 24 or above and an Informant Questionnaire on
Cognitive Decline in the Elderly score of 4.0 or less were
used for inclusion. All patients went through a standardized
procedure with neuropsychological testing and brain mag-
netic resonance imaging for evaluation of MTA. In some
cases, analysis of b amyloid and tau proteins from cerebro-
spinal fluid was also performed.
All participants underwent comprehensive eye examina-
tion and were excluded if they had retinal or optic nerve dis-
ease such as glaucoma and age-related macular degeneration
or trauma, diabetes mellitus, or other systemic diseases that
can affect the eye. The healthy cohort included individuals
with no history of cognitive impairment. All participants
were of Caucasian origin. Sixty patients were originally re-
cruited for oximetry. Thirteen patients were excluded
because of retinal or optic disc disease or because of nonat-
tendance on measurement day. In all, 47 patients went
through oximetry. From the group of 47 patients, we were
able to pair 44 with a healthy cohort, according to age (where
no more than 7 years were between paired individuals). Of
those 44, two were excluded because of bad image quality.
Therefore, the final number of included participants was
42 in each group; the MCI group and the group of healthy
control subjects.
Each participant answered a questionnaire on medical
history, medications, and smoking. Blood pressure and heart
rate were measured (Omron M6 Comfort [HEM-7000-E];Omron Healthcare Europe, Hoofddorp, the Netherlands) as
well as finger pulse oximetry (healthy cohort: Ohmeda
Biox 3700; Ohmeda, Boulder, CO, USA; patient group: Ma-
simo Rad 57, Masimo Corp., CA, USA) and intraocular
pressure (iCare Tonometer TAO1; Tiolat Oy, Helsinki,
Finland). Pupils were dilated with 1% tropicamide (My-
driacyl; S.A. Alcon-Couvreur N.V., Puurs, Belgium), which
was supplemented with 10% phenylephrine hydrochloride
(AK-Dilate; Akorn Inc., Lake Forest, IL, USA).
Magnetic resonance imaging of the brain was obtained
from every participant with visual evaluation of atrophy
of the medial temporal lobes scoring atrophy from 0 (no
atrophy) to 4 (maximal atrophy, [22]). For the purpose of
this study, the same experienced radiologist scored all the
images consecutively.
Optical coherence tomography (OCT) imaging was per-
formed on most MCI patients. Peripapillary scans were ob-
tained with Topcon 3D OCT 2000 (Topcon Inc. Tokyo,
Japan).
All the cases were diagnosed in a consensus meeting of at
least three geriatricians. Based on all available information,
the participants were grouped into one of two groups:
1. Clinical signs and biomarkers consistent with AD
(n 5 16)
2. Clinical signs of MCI but without clear biomarkers for
AD (n 5 25).
One patient had clinical signs and biomarkers that were
consistent with early Lewy body dementia.
The consensus diagnosis was made according to ICD-10
(the 10th revision of the International Statistical Classifica-
tion of Diseases and Related Health Problems by the World
health organization). Patients that did not fulfill the diag-
nosis of MCI by neuropsychological testing but still experi-
enced loss of memory were considered to be in very early
stage of MCI and were included in the study. Details on par-
ticipants can be found in Table 1.2.2. Retinal oximetry
Oximetry was performed with a dual wavelength, nonin-
vasive spectrophotometric oximeter, Oxymap T1 (Oxymap
ehf., Reykjavik, Iceland). The oximeter has been described
in details elsewhere [23]. In short, the oximeter consists of
a conventional fundus camera (Topcon TRC-50DX, Topcon
Corporation, Tokyo, Japan) with two attached digital cam-
eras. Two images of the retina at two different wavelengths,
570 nm (insensitive to oxygen saturation) and 600 nm (sen-
sitive to oxygen saturation), are simultaneously acquired,
and retinal vessel oxygen saturation is calculated from those
two images (Fig. 1).
2.2.1. Analysis of oximetry images
For every individual, both eyes were analyzed with a
specialized analysis program for Oxymap T1, Oxymap
Analyzer (version 2.2.1, revision 10927, Oxymap ehf.,
Table 1
Demographics of the study groups
Healthy MCI
Subgroups
Possible Alzheimer’s disease
according to biomarkers
MCI without biomarkers of
Alzheimer’s disease
Number 42 42 16 25
Age (years, mean 6 SD) 66 6 9 70 6 10 75 6 8 70 6 10
Heart rate (beats/min, mean 6 SD) 68 6 15 68 6 11 66 6 12 69 6 11
Finger oximetry (%, mean 6 SD) 96 6 2 98 6 8 97 6 2 97 6 1
Systolic pressure (mm Hg, mean 6 SD) 134 6 19 136 6 23 135 6 23 138 6 24
Diastolic pressure (mm Hg, mean 6 SD) 86 6 10 86 6 11 85 6 10 87 6 12
MAP (mm Hg, mean 6 SD) 102 6 12 101 6 17 98 6 22 104 6 14
Abbreviations: MAP, mean arterial pressure; MCI, mild cognitive impairment; min, minutes; SD, standard deviation.
NOTE. Heart rate, finger oximetry, and blood pressure measurements were missing for four individuals (three healthy and one MCI).
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quality graded below five (according to the Oxymap
Analyzer program). The optic disc was located in the center
of analyzed images. Oxygen saturation was measured in all
major retinal blood vessels that were between two, concen-
tric circles, 1.5–3 disc diameter, circled around the optic
disc. The minimum length of a measured vessel segment
was 50 pixels. The diameter of the same vessels was
measured. For each individual, mean values from both
eyes were averaged and the average was used for further
analysis (one value for venules and one value for arterioles
per individual).
2.3. Analysis of MTA scores
The patient group was divided into two subgroups ac-
cording to the severity of MTA scores, MTA score 2, and
MTA score ,2.
2.4. Statistical analysis
All statistical analysis was performed with GraphPad
Prism, version 7.0 (GraphPad Software Inc., La Jolla, Cali-
fornia, USA). Two-tailed, unpaired t-test was used for com-
parison of the two groups. P , .05 was considered
statistically significant.3. Results
When the whole MCI group (n 5 42) was compared to
healthy individuals (n5 42), retinal oxygen saturation in ar-
terioles was statistically significantly higher in MCI patients
(93.1 6 3.7% vs. 91.1 6 3.4%, mean 6 SD, n 5 42,
P 5 .01). The saturation in venules were also statistically
significantly increased in MCI compared to healthy individ-
uals (59.6 6 6.1% vs. 54.9 6 6.4%, P 5 .001, Fig. 2). The
arteriovenous difference in oxygen saturation was lower in
MCI patients compared to healthy individuals
(33.5 6 4.5% vs. 36.2 6 5.2%, P 5 .01).
No difference could be found between groups in vessel
width for either arterioles (P 5 .6) or venules (P 5 .5,
Table 2). There was also no difference in image quality, asmeasured by the oximetry software, between MCI patients
(quality grade 7.9 6 0.8) and healthy individuals
(7.7 6 1.0, P 5 .3).
No difference in retinal vessel oxygen saturation and arte-
riovenous difference was found between those that hadMTA
score of 2 or more and those that had less atrophy (P 5 .1–
.7). There was a correlation between decreased arteriolar ox-
ygen saturation and increased MTA scores (P5 .01) but not
between MTA scores and venular oxygen saturation
(P 5 .07) and arteriovenous difference (P 5 .6). There was
no correlation between retinal vessel oxygen saturation
and the thickness of peripapillary retina (measured with
OCT, P 5 .1–.4).
When the two subgroups (possible AD according to bio-
markers and MCI without biomarkers of AD) were
compared to paired, healthy individuals, an increase in ven-
ular oxygen saturation was found in patients with MCI
without biomarkers of AD (P5 .005), and the arteriovenous
difference was decreased in the same subgroup (P 5 .01),
Table 3. Arteriolar vessel oxygen saturation was not signif-
icantly different from healthy in either subgroup although
there was a trend toward increased saturation in patients
with neuropsychological state of MCI subgroup when
compared with healthy (P 5 .07). Vessel width (Table 3)
and image quality in the subgroups were not significantly
different from healthy individuals.4. Conclusion
The results from the study suggest that retinal arteriolar
and venular oxygen saturation is higher in MCI than in
healthy subjects. The arteriovenous difference was
decreased in MCI compared with healthy individuals. Pa-
tients with MCI without biomarkers of AD (subgroup) had
higher venular oxygen saturation and decreased arteriove-
nous difference when compared with paired, healthy indi-
viduals. This confirms and extends earlier reports by our
research group [14].
Increased venular oxygen saturation and decreased arte-
riovenous difference could indicate decreased oxygen
extraction. Other groups have measured thinning of the
Fig. 1. Fundus oximetry images from (above) a healthy individual and (below) an MCI patient. These two individuals were paired according to age. Average
retinal oxygen saturation was calculated from left and right eye for each individual. Abbreviation: MCI, mild cognitive impairment.
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venular oxygen saturation and decreased arteriovenous
difference could indicate less metabolic activity in the
tissue, which could be due to thinner RNFL. In our study,
OCT was only performed on the patient group but not the
healthy group; so unfortunately, we do not have the
comparison of RNFL thickness between these two groups.
The arterioles also have higher oxygen saturation in MCI
compared to healthy individuals.
There are some possible explanations for the increase in
retinal vessel oxygen saturation. As previously stated, thinner
RNFL with resultant decreased metabolic activity could be
one of the reasons. Fluorodeoxyglucose positron emission to-
mography has demonstrated that metabolism could beFig. 2. Retinal vessel oxygen saturation in arterioles (red) and venules
(blue). There was an increase in both arteriolar and venular oxygen satura-
tion inMCI patients when comparedwith healthy individuals. Abbreviation:
MCI, mild cognitive impairment.decreased in the brain of MCI patients [27,28]. If
metabolism and oxygen consumption is decreased in MCI,
this could also explain the decreased arteriovenous
difference that was measured in the study. Other reasons
could also explain increased venular oxygen saturation.
According to Thal et al., 82%–98% AD patients have
cerebral amyloid angiopathy, which leads to thickening of
vessel walls [29]. This leads to decreased diffusion of glucose
and oxygen from the vessels, which could increase venular
oxygen saturation. This could also explain the increase in
arteriolar oxygen saturation, that is, arterioles loose oxygen
by diffusion and this loss would decrease with thicker walls.
Similar results have been reported in diabetic retinopathy
(increased arteriolar and venular oxygen saturation), and it
has been suggested that thickening of the vessel wall could
partly explain those results [30]. Another potentialTable 2
Mean retinal oxygen saturation values and vessel width for healthy
individuals and patients with MCI
Healthy (n 5 42) MCI (n 5 42)
P value
(unpaired t-test)
Oxygen saturation (%)
Arterioles 91.1 6 3.4 93.1 6 3.7 .01
Venules 54.9 6 6.4 59.6 6 6.1 .001
AV difference 36.2 6 5.2 33.5 6 4.5 .01
Vessel width (pixels)
Arterioles 11.9 6 0.8 12.0 6 1.0 .6
Venules 15.0 6 1.4 15.1 6 1.2 .9
Abbreviation: AV, arteriovenous; MCI, mild cognitive impairment.
NOTE. Also represented are P values for comparison between groups
with an unpaired t-test.
Table 3
Retinal oxygen saturation and vessel width subgroups of patients
Subgroups
Possible Alzheimer’s
disease according to
biomarkers (n 5 16)
MCI without
biomarkers of
Alzheimer’s
disease (n 5 25)
Oxygen saturation (%)
Arterioles 93.2 6 5.0 93.0 6 2.7
Venules 58.6 6 7.8 60.2 6 5.0*
AV difference 34.6 6 5.0 32.8 6 4.1y
Vessel width (pixels)
Arterioles 12.0 6 1.0 12.0 6 1.0
Venules 15.1 6 1.1 15.0 6 1.2
Abbreviation: AV, arteriovenous; MCI, mild cognitive impairment.
NOTE. *P 5 .005; yP 5 .01 when compared to paired, healthy cohort.
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be an effect from a thinner RNFL (as discussed previously)
and a resultant decreased oxygen uptake by tissue adjacent
to an arteriole. Decreased oxygen concentration gradient be-
tween the central retinal artery and the adjacent central retinal
vein could also decrease the expected oxygen counter current
diffusion of oxygen between them.
Retinal oxygen saturation has been previously measured
in mild and moderate AD by our group [14]. We measured
increased vessel oxygen saturation in moderate AD when
compared with healthy individuals, which is in agreement
with the results from this study. Berisha et al. measured
smaller retinal venular diameter in mild-to-moderate AD
compared to healthy individuals. They also measured
decreased blood flow in retinal venules in AD [9]. Feke
et al. measured decrease in blood flow in AD and to a smaller
degree but still statistically significant, in MCI when
compared to healthy individuals [31]. They did not measure
difference in the blood column diameter in MCI when
compared to healthy individuals, which is in agreement
with our results. In agreement with Berisha et al., they did,
however, measure decreased diameter in AD. If blood flow
is decreased (such as Berisha et al. and Feke et al. measured)
and arteriovenous difference is also decreased, such as was
measured in this study, this could indicate less oxygen
extraction by the retinal tissue.
Most of the patients could be divided into two subgroups
(possible AD according to biomarkers and MCI without bio-
markers of AD). In both subgroups, the mean in arteriolar
and venular oxygen saturation was higher than for healthy
individuals. This increase in saturation reached statistical
significance only in the group with MCI without biomarkers
of AD. The low number of patients in each subgroup means
that strong conclusions cannot be drawn about possible dif-
ferences.
There are a few limitations to the study. The mean age of
the control group was lower by 4 years compared to the
mean age of MCI patients. It has been shown that age can
affect image quality, which consequently affects measured
oxygen saturation values. For example, Geirsdottir et al.measured decreased venular oxygen saturation with
increased age [23]. In this study, arteriolar and venular oxy-
gen saturation was higher in the MCI group compared to the
younger healthy group, which means that the age difference
between the two groups is an unlikely explanation for the
difference seen in saturation. Image quality was also evalu-
ated, and there was no difference found between the groups.
Unfortunately, data on RNFL thickness for the healthy
cohort did not exist, so any RNFL thickness comparison be-
tween healthy and MCI group was impossible. We per-
formed a correlation between the thickness of the RNFL
and retinal oxygen saturation for the MCI cohort but found
no correlation. Arteriolar saturation decreased with
increased size of MTA score.
In conclusion, patients with MCI have higher retinal
vessel oxygen saturation and lower arteriovenous difference
when compared to healthy individuals. This could indicate
less oxygen extraction in MCI. Further studies with larger
number of MCI patients are needed to fully evaluate whether
retinal metabolism is altered in early AD and if retinal oxy-
gen values could serve as an early biomarker for the disease.Acknowledgments
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1. Systematic review: The authors reviewed the litera-
ture using PubMed. There has only been one publica-
tion in a peer reviewed journal on retinal oximetry
and Alzheimer’s disease, which is a study conducted
by our group. Most of the studies on mild cognitive
impairment and the eye are based on retinal nerve fi-
ber layer thickness and blood flow. The relevant pub-
lications have been appropriately cited.
2. Interpretation: Our findings demonstrate an increase
in retinal venous oxygen saturation and decrease in
arteriovenous difference using a simple, noninvasive
technique. This could indicate a decrease in retinal
metabolism in patients with mild cognitive impair-
ment.
3. Future directions: It is important to measure a larger
cohort to determine whether these changes in retinal
metabolism can be used as a biomarker for early Alz-
heimer’s disease.
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